コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ortly after birth with lung hypoplasia and a ventricular septal defect.
2 nt mice have other cardiac defects including ventricular septal defect.
3 eltaI)/B(-) mice were born with a membranous ventricular septal defect.
4 viduals, as well as atrial septal defect and ventricular septal defect.
5 septum, and 6.4% for pulmonary atresia with ventricular septal defect.
6 ciation holds in patients with and without a ventricular septal defect.
7 of the IVS, hypertrophic cardiomyopathy, and ventricular septal defect.
8 etralogy of Fallot or pulmonary atresia with ventricular septal defect.
9 ocardial hypoplasia, hypertrabeculation, and ventricular septal defect.
10 poplasia, double-outlet right ventricle, and ventricular septal defect.
11 mal cardiac function, and had no evidence of ventricular septal defect.
12 entricular septum and 298 (38%) for TGA with ventricular septal defect.
13 ble outlet right ventricle with a concurrent ventricular septal defect.
14 ning defects, pulmonary artery stenosis, and ventricular septal defects.
15 ing common arterial trunk and perimembranous ventricular septal defects.
16 eptal defects and between ozone and isolated ventricular septal defects.
17 p-helix factor (CHF)1Hey2 gene show isolated ventricular septal defects.
18 developed a cardiomyopathy but did not have ventricular septal defects.
19 ions and coarctations of the aortic arch and ventricular septal defects.
20 S) including hypertrophic cardiomyopathy and ventricular septal defects.
21 al heart disease (CHD), including atrial and ventricular septal defects.
22 rdiac outflow tract alignment and membranous ventricular septal defects.
23 lar mass compared with naive pigs, developed ventricular septal defects.
24 Some mutant individuals also had heart ventricular septal defects.
25 low tract obstruction and decreased risk for ventricular septal defects.
26 t obstruction and between sertraline use and ventricular septal defects.
27 uspid valve, and perimembranous and muscular ventricular septal defects.
28 ity alleles at different loci for atrial and ventricular septal defects.
29 ackground C57Bl/6 frequently have atrial and ventricular septal defects.
30 cular septal defects and C57Bl/6 to muscular ventricular septal defects.
31 mpaction, double outlet right ventricles and ventricular septal defects.
32 interventricular septum and display profound ventricular septal defects.
33 bryonic stage with thin ventricular wall and ventricular septal defects.
34 k, -0.41 (95% CI, -0.74 to -0.09); and major ventricular septal defects, -0.25 (95% CI, -0.35 to -0.1
35 confidence interval, -0.87 to -0.10); major ventricular septal defects, -0.41 (95% confidence interv
37 vascular malformations (1.09, 1.00 to 1.18), ventricular septal defect (1.07, 0.95 to 1.21), atrial s
39 s, 2 warfarin embryopathies, 1 stillbirth, 1 ventricular septal defect, 1 growth retardation) were re
40 68-1.57) or premature CAD (OR for CoA versus ventricular septal defect, 1.44; 95% CI, 0.79-2.64) afte
41 imester infection were 1.59 (1.16, 2.20) for ventricular septal defects, 1.55 (1.21, 1.99) for atriov
42 lformation [25 (56.82%) vs. 31 (34.83%)] and ventricular septal defect [10 (22.73%) vs. 6 (6.74%)] to
43 HDs were tetralogy of Fallot (20%), isolated ventricular septal defect (14%), and transposition of th
44 ssociated cardiovascular anomalies, of which ventricular septal defects (22/47, 47%), atrial septal d
45 Overall, 400 patients, 154 (38.3%) with a ventricular septal defect, 238 (59.5%) with an intact se
46 7) hair dye in multiple/multiplex membranous ventricular septal defect, 3.3%; and 8) urinary tract in
47 % for tetralogy of Fallot, 2.7% for isolated ventricular septal defect, 3.5% for coarctation of the a
48 CAD compared with 224 of 6481 patients with ventricular septal defect (4.9% versus 3.5%; P=0.04).
49 nd associated CHD (9 atrial septal defect, 7 ventricular septal defect, 4 transposition of the great
50 6) pesticide exposure in isolated membranous ventricular septal defect, 5.5%; 7) hair dye in multiple
51 eptal defects [12.4 months sooner, P=0.037], ventricular septal defects [6.0 months sooner, P<0.003],
52 12 had Taussig-Bing anomaly, 12 had multiple ventricular septal defects, 8 had right ventricular hypo
53 If AVVI is < 0.67 in the presence of a large ventricular septal defect, a single-ventricle approach t
54 nt of the neural crest such as cleft palate, ventricular septal defect, abnormal development of hypog
55 es, including pulmonic arterial stenosis and ventricular septal defects accompanied by high peak outf
56 eeks' gestation, with d-TGA, with or without ventricular septal defects, admitted to our institution
57 ere not significantly related to presence of ventricular septal defect, age at surgery, perfusion var
58 ouble outlet right ventricle, and atrial and ventricular septal defects, all occurring with variable
59 owed structural cardiac defects, including a ventricular septal defect, an aortic root that either st
60 s of 58 patients, 3 to 57 years of age, with ventricular septal defect and a marked increase in pulmo
61 n of Ets1(-/-) embryos revealed a membranous ventricular septal defect and an abnormal nodule of cart
62 , likely resulting from a profound subaortic ventricular septal defect and associated malalignment of
63 on of the entire miR-200 family results in a ventricular septal defect and embryonic lethality by emb
66 cts in cardiovascular development, including ventricular septal defect and non-compaction, as well as
67 ing to left-to-right shunting in the form of ventricular septal defect and paradoxical thromboembolis
68 This pattern was also true for patients with ventricular septal defect and subaortic stenosis compare
69 stenosis and 12 patients with perimembranous ventricular septal defect and subaortic stenosis-and wer
70 uses, with high penetrance, large membranous ventricular septal defects and a bifid cardiac apex, and
71 fects or embryonic death, but does result in ventricular septal defects and a low incidence of semilu
74 nt article describes the clinical aspects of ventricular septal defects and current management strate
75 HDAC5 and HDAC9 show a propensity for lethal ventricular septal defects and thin-walled myocardium.
76 We report severe cardiac defects such as ventricular septal defects and thinned myocardium, place
77 e tetralogy of Fallot, overriding aorta with ventricular septal defect, and bicuspid aortic valves.
78 elopment including hypoplasia of myocardium, ventricular septal defect, and disorganized morphology.
79 including hypoplastic myocardium, membranous ventricular septal defect, and double outlet right ventr
80 uch as abnormalities of the tricuspid valve, ventricular septal defect, and pulmonary stenosis, occur
82 ht ventricle, with obligatory perimembranous ventricular septal defects, and double-sided aortic arch
83 ar valve development, bicuspid aortic valve, ventricular septal defects, and embryonic lethality.
84 e Gsk3b(-/-) embryos had a double outlet RV, ventricular septal defects, and hypertrophic myopathy, w
85 efects overall, pulmonary-artery hypoplasia, ventricular septal defects, and hypoplastic left heart.
86 sgenesis of the aortic and pulmonary valves, ventricular septal defects, and other cardiac anomalies.
87 ovascular abnormalities including atrial and ventricular septal defects, and tetralogy of Fallot, res
88 rch arteries, double-outlet right ventricle, ventricular septal defects, and thin-walled myocardium.
89 ls severe cardiac defects such as atrial and ventricular septal defects, and valvular defects includi
91 formations (aOR = 1.28; 95% CI: 1.03, 1.61), ventricular septal defect (aOR = 1.19; 95% CI: 1.00, 1.4
92 ght ventricle, transposition, and membranous ventricular septal defects), aortic sac (persistent trun
100 of the aorta (aRR, 0.77; 95% CI, 0.61-0.96), ventricular septal defects (aRR, 0.85; 95% CI, 0.75-0.96
102 ube defects, transposition of great vessels, ventricular septal defect, atrial septal defect, tetralo
103 Severe nonchromosomal CHD (ie, excluding ventricular septal defects, atrial septal defects, and p
105 k; (b) the transcatheter closure of muscular ventricular septal defects; (c) the transcatheter closur
108 mentation (n=5), mitral valvuloplasty (n=5), ventricular septal defect closure (n=4), apicoaortic con
109 c stenosis resection/Konno procedure (n=10), ventricular septal defect closure (n=8), apical aortic c
110 s associated with death after postinfarction ventricular septal defect closure included the following
111 of Fallot by the traditional technique with ventricular septal defect closure through a ventriculoto
113 with the modified technique with transatrial ventricular septal defect closure, a short infundibular
114 , aortoplasty, subaortic stenosis resection, ventricular septal defect closure, and ascending aorta r
116 lthough transcatheter valve replacements and ventricular septal defect closures have already been per
118 nce of congenital cardiac malformations like ventricular septal defects, common atrioventricular cana
119 This review discusses the different types of ventricular septal defects commonly seen in adults in th
120 mic consequences and treatment strategies of ventricular septal defects complicating acute myocardial
121 ar ventricular septal defect, perimembranous ventricular septal defect, conotruncal defects, left ven
122 for trabecular and papillary muscle defects, ventricular septal defects, conotruncal ridge defects, a
123 lar chamber (chamber hypoplasia and muscular ventricular septal defects), conotruncus (double-outlet
124 t ventricular hypertrophy, overriding aorta, ventricular septal defects, coronary vessel abnormalitie
125 ntal abnormalities include overriding aorta, ventricular septal defects, cranial nerve, and craniofac
126 tro-transposition of the great arteries with ventricular septal defect (d-TGA-VSD), and double-outlet
127 the transcatheter closure of perimembranous ventricular septal defects; (d) the placement of biopros
129 eptal defects using the Amplatzer membranous ventricular septal defect device have been encouraging.
130 on of the delivery system for the membranous ventricular septal defect device that is aimed to overco
133 decreasing NMII-B by 80% results in cardiac (ventricular septal defect, double outlet of the right ve
134 eart defects (CHD) which included atrial and ventricular septal defects, double outlet right ventricl
135 g Jun in Isl1-expressing progenitors display ventricular septal defects, double outlet right ventricl
137 e flow measurements of mitral regurgitation, ventricular septal defect flow and aortic regurgitation.
138 from 1.9 per mille to 4.1 per mille, and of ventricular septal defect from 3.6 per mille to 4.5 per
139 s, such as operative urgency and postinfarct ventricular septal defect, have been relatively stable o
140 t defects (persistent truncus arteriosus and ventricular septal defect), hypoplastic lungs, hypoplast
142 syndrome was present in 31% (n = 46 of 149), ventricular septal defect in 95% (n = 142 of 149), and p
143 s associated with ventricular hypoplasia and ventricular septal defects in beta-myosin heavy chain-mi
145 0.15); however, the incidence of membranous ventricular septal defects in Nkx2-5 mutant hearts was n
146 hereas deletion of both miRNAs causes lethal ventricular-septal defects in approximately half of doub
148 significantly increased by the presence of a ventricular septal defect, left ventricular outflow obst
152 mbryos showed heart malformations, including ventricular septal defect, noncompaction of the ventricu
153 ently used devices were the Vascular Plug 3, Ventricular Septal Defect Occluder, Vascular Plug 2, and
154 test odds of offspring with a perimembranous ventricular septal defect (odds ratio = 3.23, 95% confid
155 1.43, 3.60), and sulfur dioxide and isolated ventricular septal defects (odds ratio = 2.16, 95% confi
156 all or large IVS, appears to confer risk for ventricular septal defect or hypertrophic cardiomyopathy
157 in patients with acute mitral regurgitation, ventricular septal defect or poor left ventricular funct
158 s and cross-clamp times, and the presence of ventricular septal defects or abnormal coronary anatomy.
159 redictors of failure included moderate/large ventricular septal defect (OR=22, P=0.001), unicommissur
160 t defects (OR = 0.46; 95% Cl 0.24, 0.86) and ventricular septal defects (OR = 0.61; 95% Cl: 0.38, 0.9
161 struction (OR, 1.28 [95% CI, 1.10-1.49]) and ventricular septal defects (OR, 0.92 [95% CI, 0.86-0.98]
162 abundant endocardial cushions accompanied by ventricular septal defects, outflow tract abnormalities
166 persistent left superior vena cava (P=0.85), ventricular septal defect (P=0.12), and bicuspid aortic
167 ly implicated (ie, in 90.0%) was between the ventricular septal defect patch and pulmonary annulus.
169 to-tricuspid annulus, (1B) ventriculotomy-to-ventricular septal defect patch, (2) ventriculotomy-to-p
170 -pulmonary annulus, (3) pulmonary annulus-to-ventricular septal defect patch, and (4) ventricular sep
171 -to-ventricular septal defect patch, and (4) ventricular septal defect patch-to-tricuspid annulus.
173 ed in the outflow tract (99%) or the site of ventricular septal defect patching (98%) and in the infe
174 peroxia 1.51 0.04) and frequency of muscular ventricular septal defects per heart (1.53 0.32 vs. 0.68
175 with intact ventricular septum and TGA with ventricular septal defect performed from 2010 to 2013.
176 ransposition of the great arteries, muscular ventricular septal defect, perimembranous ventricular se
177 rabeculation defects in the right ventricle, ventricular septal defect, persistent truncus arteriosus
180 patients with a posterior malalignment type ventricular septal defect (PMVSD) and only 1 of 20 patie
181 ck) after operative repair of perimembranous ventricular septal defect (PMVSD) in a large multi-insti
182 s of transcatheter closure of perimembranous ventricular septal defects (PmVSDs) using the new Amplat
183 ation secondary to papillary muscle rupture, ventricular septal defect, pseudoaneurysm, and free wall
184 ial septal defect, patent ductus arteriosus, ventricular septal defect, pulmonary artery anomalies, p
185 or anomalies, include pulmonary atresia with ventricular septal defect, pulmonary valve agenesis, aor
186 tract obstruction (ratio of RRs, 4.98), and ventricular septal defects (ratio of RRs, 2.51) but not
187 than mild tricuspid regurgitation, residual ventricular septal defect) reduces this protective assoc
189 o 1.93) or between the use of sertraline and ventricular septal defects (relative risk, 1.04; 95% CI,
190 ions overall, cardiac malformations overall, ventricular septal defect, secundum atrial septal defect
191 ion of mXinbeta led to abnormal heart shape, ventricular septal defects, severe growth retardation, a
192 the neonatal period as well as for muscular ventricular septal defects should be the transcatheter a
193 lial-specific NSML SHP2 expression developed ventricular septal defects, suggesting that NSML-associa
194 veal that > or = 2 loci influence membranous ventricular septal defect susceptibility, whereas > or =
195 e (Cx40+/-) included bifid atrial appendage, ventricular septal defect, tetralogy of Fallot (TOF), an
196 eath after surgery for atrial septal defect, ventricular septal defect, tetralogy of Fallot, and tran
197 all patients with CHD (atrial septal defect, ventricular septal defect, tetralogy of Fallot, Ebstein
198 spectrum of cardiac malformations including ventricular septal defects, tetralogy of Fallot, and tri
199 ular septum (TGA/IVS, n = 79, 63%), TGA with ventricular septal defect (TGA/VSD, n = 37, 30%), and Ta
200 Five experienced 3 of 76 (3.9%) iatrogenic ventricular septal defects that did not require repair a
201 e but have severe dilated cardiomyopathy and ventricular septal defects that mimic a human congenital
202 ndromic patients with isolated atrial and/or ventricular septal defects, the predominant cardiac defe
204 ate, cleft palate only, conotruncal defects, ventricular septal defects, urinary tract defects, limb
205 tflow tract and creation or enlargement of a ventricular septal defect using stents are potential the
206 results of device closure of perimembranous ventricular septal defects using the Amplatzer membranou
207 egrees and 0 degree), presence/location of a ventricular septal defect (VSD) (3-mm VSD; 2 and 6 mm fr
208 rmine the accuracy of expert examination for ventricular septal defect (VSD) among children with a he
209 ar to those in the human proband, as well as ventricular septal defect (VSD) and double-outlet right
211 nd the presence of MAPCAs, with TOF, PA, and ventricular septal defect (VSD) being the most common, a
216 urvival of patients with isolated congenital ventricular septal defect (VSD) is not well described.
217 enmenger syndrome when two ventricles with a ventricular septal defect (VSD) joined two great arterie
218 = 251), coarctation or interrupted arch with ventricular septal defect (VSD) repair (n = 150), and No
220 tive data for atrial septal defect (ASD) and ventricular septal defect (VSD) surgeries in children 2
221 etrical and a moderate-sized apical muscular ventricular septal defect (VSD) was diagnosed after birt
222 efects in cardiac morphogenesis, including a ventricular septal defect (VSD), abnormal formation of t
223 odel, we observed an increased risk of CHDs, ventricular septal defect (VSD), and tetralogy of fallot
224 cts including double-outlet right ventricle, ventricular septal defect (VSD), atrioventricular (AV) c
225 which 6 were thought to have a subpulmonary ventricular septal defect (VSD), had incorrect prenatal
226 O for dTGA with intact ventricular septum or ventricular septal defect (VSD), including double-outlet
227 e types of congenital heart disease, such as ventricular septal defect (VSD), myocardium noncompactio
228 as double outlet right ventricle (DORV) and ventricular septal defect (VSD), similar to defects obse
236 e birth defects (atrial septal defect [ASD], ventricular septal defect [VSD], tetralogy of Fallot [TO
239 nd environmental factors on the incidence of ventricular septal defects (VSDs) caused by a heterozygo
240 heter or surgical closure of apical muscular ventricular septal defects (VSDs) requires accurate deli
241 try of device closure of congenital muscular ventricular septal defects (VSDs) using the new Amplatze
243 ncation and kinking with 100% penetrance and ventricular septal defects (VSDs) with ~15% penetrance;
245 CHD was related to the relative frequency of ventricular septal defects (VSDs), the most common type
255 isk of specific birth defects, only that for ventricular septal defects was significantly elevated, w
257 exception of a single baby with an isolated ventricular septal defect, which closed spontaneously, n
258 t defect including cardiac noncompaction and ventricular septal defect, which phenocopies 1p36 deleti
259 cell cycling, ventricular noncompaction, and ventricular septal defects, while, in the postnatal card
260 compared patients with CoA and those with a ventricular septal defect, who are not known to be at in
261 sted cardiac disease, including classic ToF, ventricular septal defect with aortic dextroposition and
262 tation and on the left-ventricular side of a ventricular septal defect with left-to-right shunting.
264 =3), functionally single ventricle (n=3) and ventricular septal defect with pulmonary outflow obstruc
265 36), or transposition of the great arteries, ventricular septal defect with pulmonary stenosis (n=8).
266 xhibit cardiac ventricular wall thinning and ventricular septal defects with double outlet right vent
267 ew strains model a specific subtype of atrio-ventricular septal defects with exclusive ventricular sh